News
-
-
COMMUNIQUÉ DE PRESSE
Nemetschek Group continues its very strong and profitable growth in Q3 2025 and reconfirms its updated guidance for the full year 2025
Nemetschek Group reports strong growth and reconfirms guidance for 2025, with revenue up 20.0% in Q3 to EUR 293.1 million. EBITDA increases to EUR 95.2 million, showing a margin improvement to 32.5% -
COMMUNIQUÉ DE PRESSE
Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial -
COMMUNIQUÉ DE PRESSE
Valneva annonce des résultats positifs de Phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika
Valneva annonce des résultats positifs de phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika, montrant une réponse immunitaire améliorée -
-
COMMUNIQUÉ DE PRESSE
Cognizant Adopts Anthropic's Claude to Accelerate Enterprise AI Adoption at Scale and Deploys Claude to Drive Internal AI Transformation
Cognizant adopts Anthropic's Claude for enterprise AI adoption at scale and internal AI transformation, combining large language models with engineering platforms -
-
-
-
